$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Decreased messenger RNA expression of key markers of the nigrostriatal dopaminergic system following vitamin E deficiency in the rat

Neuroscience, v.101 no.4, 2000년, pp.1029 - 1036  

Romero-Ramos, M (Departamento de Bioquı) ,  Venero, J.L (́) ,  Santiago, M (mica, Bromatologı) ,  Rodriguez-Gómez, J.A (́) ,  Vizuete, M.L (a, Toxicologı) ,  Cano, J (́) ,  Machado, A (a y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Calle Profesor Garcı)

Abstract AI-Helper 아이콘AI-Helper

AbstractWe have evaluated the effect of a vitamin E-deficient diet on the rat nigrostriatal dopaminergic system. After 15days of deficient diet, the amount and activity of striatal and nigral tyrosine hydroxylase increased, which contrasted with a decreased messenger RNA expression for tyrosine hydr...

주제어

참고문헌 (41)

  1. Brain Res. Rev. Bains 25 335 1997 10.1016/S0165-0173(97)00045-3 Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death 

  2. Ann. N. Y. Acad. Sci. Burton 570 7 1989 10.1111/j.1749-6632.1989.tb14904.x Vitamin E as an in vitro and in vivo antioxidant 

  3. Neuroscience Castano 53 179 1993 10.1016/0306-4522(93)90296-R Effect of a short period of vitamin E deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat 

  4. Brain Res. Rev. Connor 27 1 1998 10.1016/S0165-0173(98)00004-6 The role of neuronal growth factors in neurodegenerative disorders of the human brain 

  5. NeuroReport Dexter 5 1773 1994 10.1097/00001756-199409080-00022 Nigral dopaminergic cell loss in vitamin E deficient rats 

  6. Ann. Neurol. Dexter 35 298 1994 10.1002/ana.410350309 Nigrostriatal function in vitamin E deficiency: clinical, experimental and PET studies 

  7. Neuroscience Diaz 65 731 1995 10.1016/0306-4522(94)00527-C Phenotypical characterisation of neurons expressing the dopamine D3 receptor in the rat brain 

  8. J. biol. Chem. Evens 76 273 1928 10.1016/S0021-9258(18)84127-8 Development of paralysis in the suckling young mothers deprived of vitamin E 

  9. Proc. natn. Acad. Sci. USA Grima 82 671 1985 10.1073/pnas.82.2.617 Complete code sequence of a rat tyrosine hydroxylase mRNA 

  10. J. Neurochem. Halliwell 59 1609 1992 10.1111/j.1471-4159.1992.tb10990.x Reactive oxygen species and the central nervous system 

  11. Neurology, Suppl. Jenner 47 S161 1996 10.1212/WNL.47.6_Suppl_3.161S Oxidative stress and the pathogenesis of Parkinson’s disease 

  12. Nature, Lond. Laemmli 227 680 1970 10.1038/227680a0 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 

  13. Analyt. Biochem. Lenz 177 419 1989 10.1016/0003-2697(89)90077-8 Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride 

  14. Meth. Enzym. Levine 186 464 1990 10.1016/0076-6879(90)86141-H Determination of carbonyl content in oxidatively modified proteins 

  15. Science Lewin 236 1420 1985 10.1126/science.3109033 Drug trial for Parkinson’s 

  16. Archs Biochem. Biophys. Liu 302 118 1993 10.1006/abbi.1993.1189 Monoamime metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage 

  17. J. biol. Chem. Lowry 193 265 1951 10.1016/S0021-9258(19)52451-6 Protein measurement with the Folin phenol reagent 

  18. Curr. Opin. Neurobiol. Lozano 8 783 1998 10.1016/S0959-4388(98)80122-0 New developments in understanding the etiology of Parkinson’s disease and its treatment 

  19. Fedn Proc. Mason 36 1906 1977 The first two decades of vitamin E 

  20. Lancet Muller 1 225 1983 10.1016/S0140-6736(83)92598-9 Vitamin E and neurological function 

  21. Neuroscience Murray 60 37 1994 10.1016/0306-4522(94)90202-X Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer’s disease 

  22. NeuroReport Narisawa-Saito 7 2925 1996 10.1097/00001756-199611250-00024 Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer’s disease 

  23. Pharmac. Res. Pasinetti 21 299 1989 10.1016/S1043-6618(89)80008-8 Combined in situ hybridisation and immunocytochemistry in the assay of the pharmacological effects on tyrosine hydroxylase mRNA concentration 

  24. Molec. Brain Res. Pasinetti 5 203 1989 10.1016/0169-328X(89)90036-3 Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra 

  25. Molec. Brain Res. Pasinetti 13 63 1992 10.1016/0169-328X(92)90045-D Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging 

  26. Paxinos 1986 The Rat Brain in Stereotaxic Coordinates 

  27. Neuron Phillips 7 695 1991 10.1016/0896-6273(91)90273-3 BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease 

  28. Life Sci. Reinhard 39 2185 1986 10.1016/0024-3205(86)90395-4 A rapid and sensitive assay for tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of (3H)tyrosine by charcoal 

  29. Molec. Brain Res. Rodriguez-Gomez 46 31 1997 10.1016/S0169-328X(96)00270-7 Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system 

  30. New Engl. J. Med. Roseblum 304 503 1981 10.1056/NEJM198102263040902 A progressive neurologic syndrome with chronic liver disease 

  31. A. Rev. Pharmac. Toxic. Simonian 36 83 1996 10.1146/annurev.pa.36.040196.000503 Oxidative stress in neurodegenerative disease 

  32. Am. J. Med. Sobrevilla 57 821 1964 10.1016/0002-9343(64)90030-0 Demyelinating central nervous system disease, macular atrophy and acanthocytosis (Bassen-Kornzweig syndrome) 

  33. Free Radic. Biol. Med. Sokol 6 189 1989 10.1016/0891-5849(89)90117-2 Vitamin E and neurologic function in man 

  34. Mayo Clin. Proc. Southorn 63 390 1988 10.1016/S0025-6196(12)64862-9 Free radicals in medicine. II: Involvement in human disease 

  35. Free Radic. Biol. Med. Stadtman 9 315 1990 10.1016/0891-5849(90)90006-5 Metal-ion catalyzed oxidation of protein biochemical mechanism and biological consequences 

  36. Eur. J. Pharmac. Stoof 375 75 1999 10.1016/S0014-2999(99)00260-5 Leads for the development of neuroprotective treatment in Parkinson’s disease and brain imaging methods for estimating treatment efficacy 

  37. Brain Res. Venero 672 153 1995 10.1016/0006-8993(94)01368-R Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system 

  38. J. Neurochem. Venero 68 2458 1997 10.1046/j.1471-4159.1997.68062458.x Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: detection of oxidatively modified proteins in substantia nigra 

  39. Neurobiol. Aging Volicer 11 567 1990 10.1016/0197-4580(90)90119-K Involvement of free radicals in dementia of Alzheimer type: a hypothesis 

  40. J. Neurosci. Weiser 13 3472 1993 10.1523/JNEUROSCI.13-08-03472.1993 Differential spatial and temporal gene expression in response to axotomy and deafferation of the medial forebrain bundle 

  41. Molec. Brain Res. Weiser 17 319 1993 10.1016/0169-328X(93)90017-J Axotomy induced differential gene induction in neurons of the locus coeruleus and substantia nigra 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로